Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study

Eustachio Nettis, Michela Ortoncelli, Giovanni Pellacani, Caterina Foti, Elisabetta Di Leo, Cataldo Patruno, Franco Rongioletti, Giuseppe Argenziano, Luigi Macchia, Simona Tavecchio,

Journal of Investigational Allergology and Clinical Immunology · 2020 · 63 citations · 32 references

DOIFull text

Open access

Abstract

This is the broadest real-life study in AD patients treated with dupilumab to date. We observed more significant improvements induced by dupilumab in adult patients with moderate-to-severe AD than those reported in clinical trials.

References

32